Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17

ConclusionOur data suggest that CT-P17 may be used without any significant loss of stability when stored at 5  °C or 25 °C with 60% relative humidity for up to 28 days, and was not impacted by protein concentration tested and delivery device. Comparative stability data suggest that the appropriate maximum storage period for CT-P17 may be up to 28 days at room temperature with 60% relative humidity.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research